KANG [iKang Healthcare] UPLOAD:
[]
OIIM [O2MICRO INTERNATIONAL] 6-K: FORM 6-K O2MICRO INTERNATIONAL LIMITED Grand Pavilion Commercial
[FORM 6-K O2MICRO INTERNATIONAL LIMITED Grand Pavilion Commercial Centre, West Bay Road P.O. Box 32331 SMB, George Town Grand Cayman, Cayman Islands x ¨ Form 20-F ¨ Note ¨ Note ¨ x O2Micro International Limited (the “Company”) established Friday, July 17, 2015 as the date of the Company’s 2015 annual general meeting (the “2015 Annual General Meeting”). This Form 6-K]
GSH [GUANGSHEN RAILWAY CO] 6-K: (Original Filing)
[(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) 2014 ANNUAL RESULT ANNOUNCEMENT Company The Board of Directors of Guangshen Railway Company Limited (the 014 015 Chapter 2 Company Profile I. GENERAL INFORMATION OF THE COMPANY 1. Company Information Registered Chinese Name Abbreviation in Chinese Registered English Name Legal Representative Guangshen Railway Company]
YZC [YANZHOU COAL MINING CO] 6-K: (Original Filing)
[Yanzhou Coal Mining Company Limited Date By Zhang Baocai Director and Company Secretary YANZHOU COAL MINING COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 1171) 2014 ANNUAL RESULTS ANNOUNCEMENT FOR THE PERIOD ENDED 31 DECEMBER 2014 Board Company The board of directors (the As at the date of]
CPHI [CHINA PHARMA] 10-K: (Original Filing)
[o x x o Large accelerated filer o Accelerated filer o Non-accelerated filer Do not check if a smaller reporting company x Smaller reporting company ¨ x Documents Incorporated by Reference: None. 2 FORM 10-K ANNUAL REPORT FISCAL YEAR ENDED DECEMBER 31, 2014 TABLE OF CONTENTS PAGE PART I] [Re: Service about being [Job Position] of China Pharma Holdings, Inc. [Date/Month/Year] Dear [ ], On behalf of the Board of Directors (the “Board”) of China Pharma Holdings, Inc. (the “Company”), I am pleased to welcome you to join the Board as [Job Position]. I look forward to working with you. Your starting date will be the date on which] [Loans Extension Confirmation Letter Reference is made to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the “Company”), the principal and accumulated interest totaled USD1,354,567 and USD44,213 respectively as of December 31, 2014. Due to the fact the Company temporarily did not have enough balance in its oversea account to repay the loans, both Ms. Tsui] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our report dated March 30, 2015 relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries as of and for the year ended December 31, 2014 appearing] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 30, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 7 cphi10kex321123114.htm]
GSH [GUANGSHEN RAILWAY CO] 6-K: (a joint stock limited company incorporated in the
[(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) 2014 ANNUAL RESULT ANNOUNCEMENT Company The Board of Directors of Guangshen Railway Company Limited (the 014 015 Chapter 2 Company Profile I. GENERAL INFORMATION OF THE COMPANY 1. Company Information Registered Chinese Name Abbreviation in Chinese Registered English Name Legal Representative Guangshen Railway Company]
YZC [YANZHOU COAL MINING CO] 6-K: Yanzhou Coal Mining Company Limited Date By Zhang
[Yanzhou Coal Mining Company Limited Date By Zhang Baocai Director and Company Secretary YANZHOU COAL MINING COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 1171) 2014 ANNUAL RESULTS ANNOUNCEMENT FOR THE PERIOD ENDED 31 DECEMBER 2014 Board Company The board of directors (the As at the date of]
CPHI [CHINA PHARMA] 10-K: o x x o Large accelerated filer o
[o x x o Large accelerated filer o Accelerated filer o Non-accelerated filer Do not check if a smaller reporting company x Smaller reporting company ¨ x Documents Incorporated by Reference: None. 2 FORM 10-K ANNUAL REPORT FISCAL YEAR ENDED DECEMBER 31, 2014 TABLE OF CONTENTS PAGE PART I] [Re: Service about being [Job Position] of China Pharma Holdings, Inc. [Date/Month/Year] Dear [ ], On behalf of the Board of Directors (the “Board”) of China Pharma Holdings, Inc. (the “Company”), I am pleased to welcome you to join the Board as [Job Position]. I look forward to working with you. Your starting date will be the date on which] [Loans Extension Confirmation Letter Reference is made to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the “Company”), the principal and accumulated interest totaled USD1,354,567 and USD44,213 respectively as of December 31, 2014. Due to the fact the Company temporarily did not have enough balance in its oversea account to repay the loans, both Ms. Tsui] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our report dated March 30, 2015 relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries as of and for the year ended December 31, 2014 appearing] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 30, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 7 cphi10kex321123114.htm]
